Company
Sanguine Bio
Your committed partner for disease-state and healthy biospecimens
Also known as Sanguine Biosciences
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- many of the world's leading pharmaceutical and biotechnology companies
- Legal name
- Sanguine BioSciences
Claim, correct or request removal
Record updated 28 September 2026
About
Sanguine Biosciences is accelerating discovery through manufacturing for research in therapeutics and diagnostics by finding the biospecimens needed through our direct-to-donor model. We lower the barrier for people to participate in research by donor engagement and ease in participating - often collections occurring in the donor's home. For researchers, they receive high-quality biospecimens with comprehensive donor data.
Funding snapshot
- Total raised
- $5.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.5M2014-11-14
Funding rounds
- Round, 2014
- $5.5M2014-11-14, SEC form D sold, 74 investors
Loading relationship preview